- Operationally, Noxopharm has approximately three quarters of operating cash flows remaining, based on current cash holdings and a forecast operating cash outflow of circa$1.35m per quarter moving forward.
- The company continues to be vigilant with its cash resources and is exploring a range ofoptions in relation to securing additional capital. It is looking at its strategic plan and exploringthe likelihood of short-term catalysts which may impact the timing and range of options tosecure follow-on funding.
CR before year end?
Ann: March 2024 Quarterly Activities Report and Appendix 4C, page-2
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.37M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 7.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.0¢ | 21000 | 2 |
View Market Depth
| Last trade - 16.17pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.8¢ |
Change
0.000 ( 2.50 %) |
||||
| Open | High | Low | Volume | ||
| 7.8¢ | 7.8¢ | 7.8¢ | 7411 | ||
| Last updated 15.11pm 30/05/2024 ? | |||||
| NOX (ASX) Chart |
Day chart unavailable